N/AStarting soon
Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group
About this study
Phase IV, multi-site, open-label, non-randomized study of the pharmacokinetics (PK) of long-acting injectable cabotegravir and rilpivirine (CAB LA + RPV LA) during pregnancy and postpartum.
Enrolling at this location
Site 5048, University of Southern California
Los Angeles, California
I'm interestedThis study also enrolls at 9 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.